Decreased expression of updated NESG1 in nasopharyngeal carcinoma: Its potential role and preliminarily functional mechanism
Open Access
- 16 August 2010
- journal article
- carcinogenesis
- Published by Wiley in International Journal of Cancer
- Vol. 128 (11), 2562-2571
- https://doi.org/10.1002/ijc.25595
Abstract
Human NESG1 (CCDC19) gene was originally isolated in our laboratory from human nasopharynx tissue. However, the biological and clinical significances of this gene remain largely unknown. In this report, two errors in the originally submitted sequence of human NESG1 gene were found, and the open reading frame sequence of NESG1 (Accession number: NM_012337.1) was revised and updated in the NCBI database (Accession number: NM_012337.2). The antibody raised against the revised sequence of NESG1 detected a single band of 66 kD in human nasopharynx tissues. NESG1 transcripts were specifically expressed in the nasopharynx epithelium. Expression of NESG1 transcripts and protein was downregulated or absent in nasopharyngeal carcinoma (NPC) tissues and cell lines in comparison to that in the normal nasopharynx tissues. The levels of NESG1 protein were significantly greater in the low-grade NPC tissues than that in the high-grade NPC tissues. Induced expression of NESG1 in otherwise NESG1-negative 5-8F cells not only significantly decreased cell proliferation, G1-S phase transition, but also markedly inhibited the ability of cell migration and invasion as well as in vivo tumorigenesis. Furthermore, NESG1 also significantly regulated the expression of cell cycle regulator CCNA1 and p21. Our findings first provided evidence that NESG1 may act as a tumor suppressor by inhibiting cell proliferation, invasion and migration of NPC cells.Keywords
This publication has 29 references indexed in Scilit:
- Increased expression of MMP9 is correlated with poor prognosis of nasopharyngeal carcinomaBMC Cancer, 2010
- Over-expression of eukaryotic translation initiation factor 4 gamma 1 correlates with tumor progression and poor prognosis in nasopharyngeal carcinomaMolecular Cancer, 2010
- Intensive expression of Bmi-1 is a new independent predictor of poor outcome in patients with ovarian carcinomaBMC Cancer, 2010
- The polycomb group protein Bmi-1 represses the tumor suppressor PTEN and induces epithelial-mesenchymal transition in human nasopharyngeal epithelial cellsJCI Insight, 2009
- p21 CIP1 attenuates Ras- and c-Myc-dependent breast tumor epithelial mesenchymal transition and cancer stem cell-like gene expression in vivoProceedings of the National Academy of Sciences, 2009
- LMP1-augmented kappa intron enhancer activity contributes to upregulation expression of Ig kappa light chain via NF-kappaB and AP-1 pathways in nasopharyngeal carcinoma cellsMolecular Cancer, 2009
- p53-Altered FBXW7 Expression Determines Poor Prognosis in Gastric Cancer CasesCancer Research, 2009
- Multiple Cellular Mechanisms Related to Cyclin A1 in Prostate Cancer Invasion and MetastasisJNCI Journal of the National Cancer Institute, 2008
- Consistent expression of the stem cell renewal factor BMI‐1 in primary and metastatic melanomaInternational Journal of Cancer, 2007
- Initial sequencing and analysis of the human genomeNature, 2001